Teladoc Health, Inc.: insider trades · United States · SEC (Form 4)

About Teladoc Health, Inc.

Teladoc Health, Inc. (NYSE: TDOC) is a US-listed virtual healthcare company headquartered in Purchase, New York, United States. Founded in 2002, Teladoc was an early mover in large-scale telemedicine and has evolved from a pure teleconsultation provider into a broader whole-person virtual care platform. For European investors, the key takeaway is that Teladoc sits at the intersection of healthcare services and technology-enabled care delivery, with a model primarily driven by enterprise relationships rather than direct consumer demand alone. The company’s business is organized around two reportable segments. Integrated Care includes virtual medical visits, expert medical opinions, chronic care programs, mental health offerings, and preventive care solutions delivered through employers, health plans, health systems, and other institutions. BetterHelp is the company’s direct-to-consumer mental health platform, connecting users with licensed therapists through an online subscription model. Teladoc also offers licensable platform services, analytics, and related digital health capabilities, which broaden its role across the patient journey from initial access to follow-up care. Teladoc’s history is closely tied to the rise of telehealth in the United States. Over time, the company expanded through acquisitions and brand integration, adding assets such as BetterHelp and other specialist virtual-care capabilities to deepen its product suite. That consolidation helped Teladoc build a globally recognized brand and a sizable enterprise footprint. The company has historically emphasized its international reach and its ability to serve a large and diverse customer base across multiple healthcare channels. From a competitive standpoint, Teladoc remains one of the best-known names in virtual care, but the market has become more demanding. Post-pandemic normalization, pricing pressure, and higher customer-acquisition costs have weighed on growth and profitability. In its full-year 2024 results, Teladoc reported revenue of $2.57 billion, down slightly year over year, alongside a significant net loss, while adjusted EBITDA and cash generation remained positive. The Integrated Care segment showed relative resilience, whereas BetterHelp continued to face a challenging operating environment. Recent strategic developments are important for investors. In early 2025, Teladoc announced an agreement to acquire Catapult Health, a move intended to strengthen preventive care and chronic-care capabilities and expand at-home testing. Management has also highlighted cost-reduction actions, organizational streamlining, and efforts to stabilize BetterHelp while accelerating international growth. These steps suggest a stronger focus on efficiency and on improving the quality of growth rather than pursuing volume at any cost. In short, Teladoc Health is a NYSE-listed United States healthcare platform with meaningful scale, recognized branding, and a diversified virtual-care offering. The investment case depends on whether the company can convert its broad market position into more durable profitability and sustained segment-level growth, especially as virtual care competition intensifies and reimbursement dynamics continue to evolve.